BLIN vs VRTX · rev $15.4M vs P/E 30, rev $3.33B
Bridgeline Digital Inc (BLIN) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
Bridgeline Digital Inc (BLIN) is a software - infrastructure company listed on NASDAQ.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported BLIN revenue for 2024-09-30 was $15.4M. Net income was -$2.0M. Revenue was down 3.3% from 2023-09-30 to 2024-09-30. BLIN currently screens at market cap $13.4M.
Latest reported VRTX revenue for 2026-06-30 was $3.33B. Net income was $1.10B. Revenue was up 11.6% from 2026-03-31 to 2026-06-30. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
BLIN currently screens at market cap $13.4M. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the BLIN and VRTX stock pages for the full models.
Not investment advice.